Scientists have identified an enzyme that promotes cell proliferation in the most common and lethal ovarian cancer and could serve as a treatment target.
New research in mice identifies a compound that significantly improves ovarian cancer survival by targeting stem-like cancer cells.
During a hysterectomy, a surgeon removes a person’s uterus. Because the surgeon usually leaves part or all of the ovaries intact, it may still be possible to develop ovarian cancer. However, research suggests that any type of hysterectomy helps reduce a person’s risk of ovarian cancer. Learn more here.
Most causes of missed or irregular periods are not serious. However, less commonly, a missed period can be a sign of ovarian cancer. Early detection and treatment of this type of cancer can improve a person’s outlook. Learn more here.
Knowing the statistics on ovarian cancer can help a person better understand the condition. However, it is important to remember that everyone has a different experience with cancer.
Ovarian cancer is rarely detected in its early stages, which makes treatment less effective. A new blood test, however, may become a game-changer.
An analysis of data from two large cohorts totaling 205,498 women sees that regularly taking low-dose aspirin is linked to reduced risk of ovarian cancer.
A large study examines the effect of newer combined oral contraceptives on the risk of ovarian cancer among women of reproductive age.
New research reveals that, to fuel tumor invasion of nearby tissue, ovarian cancer cells recruit supporting cells to supply energy from glycogen.
Antibody immunotherapy for solid tumors has shown limited success. Now, one that attacks two targets in ovarian cancer cells promises to improve prospects.